Tuberculosis treatment in a refugee and migrant population: 20 years of experience on the Thai-Burmese border
SETTING: Although tuberculosis (TB) is a curable disease, it remains a major global health problem and an important cause of morbidity and mortality among vulnerable populations, including refugees and migrants.OBJECTIVE: To describe results and experiences over 20 years at a TB programme in refugee...
Saved in:
Published in: | The international journal of tuberculosis and lung disease Vol. 14; no. 12; pp. 1589 - 1595 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Paris, France
IUATLD
01-12-2010
International Union against Tuberculosis and Lung Disease |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | SETTING: Although tuberculosis (TB) is a curable disease, it remains a major global health problem and an important cause of morbidity and mortality among vulnerable populations, including refugees and migrants.OBJECTIVE: To describe results and experiences over 20 years at a TB
programme in refugee camps on the Thai-Burmese border in Tak Province, Thailand, and to identify risk factors associated with adverse outcomes (e.g., default, failure, death).DESIGN: Retrospective review of routine records of 2425 patients admitted for TB treatment in the Mae La TB programme
between May 1987 and December 2005.RESULTS: TB cases notified among refugees decreased over 20 years. Among patients treated with a first-, second- or third-line regimen, 77.5% had a successful outcome, 13.5% defaulted, 7.6% died and 1.3% failed treatment. Multivariate analysis for new
cases showed higher likelihood of adverse outcomes for patients who were Burmese migrants or Thai villagers, male, aged >15 years or with smear-negative pulmonary TB.CONCLUSION: These findings suggest that treatment outcomes depend on the programme's capacity to respond to specific
patients' constraints. High-risk groups, such as migrant populations, need a patient-centred approach, and specific, innovative strategies have to be developed based on the needs of the most vulnerable and marginalised populations. |
---|---|
Bibliography: | 1027-3719(20101201)14:12L.1589;1- (R) Medicine - General ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 1027-3719 1815-7920 |